MEDIA

Talking about zebrafish

May 2018
09

ZeClinics’ Pick of the Week: The Future of Neurological Drug Development

ZeClinics’ Pick of the Week: Trending now! Luc Truyen from Janssen, Ricardo Dolmetsch from Novartis and many more talk about fighting neurodisorders.

Read More
May 2018
02

ZeClinics’ Pick of the Week: Outsourcing is In!

ZeClinics’ Pick of the Week: How to downsize your pharma business & boost capital efficiency while remaining tech-sharp? Two words… CRO outsourcing!

Read More
April 2018
25

ZeClinics’ Pick of the Week: Zebrafish Eases the Pain of Both Gout and Traditional Disease Models

A great piece on gout and zebrafish translatability for all the trendy autoimmune and inflammation experts out there!

Read More
April 2018
11

ZeClinics’ Pick of the Week: Repurposed cancer drugs transform children’s lives

Learn how Dr. Patton and Dr. Kinsler tackle the need for pediatric drug development and drug repositioning with our little, but great, zebrafish.

View full article
Read More
April 2018
04

ZeClinics’ Pick of the Week: Signaling Proteins, Pacemaker Cells and Cardiac Rhythms

Latest discovery on cardiac developmental signals by Silja Burkhard and Jeroen Bakkers from Hubrecht Institute will make your heart skip a beat.

View full article
Read More
March 2018
26

Sergio Jarque joins ZeClinics Services Department

Dr. Sergio Jarque represents a valuable addition to the scientific department.

Read More
March 2018
09

UK Biology Research May Lead to Treatment for Blinding Disorders, Including Glaucoma

If you, like us at ZeClinics, are into ophthalmology, then Jakub Famulski from the University of Kentucky and his state-of- the-art zebrafish work might just... catch your eye.

Read More
February 2018
26

Mireia Alarcón and Ricardo Álvarez-Cienfuegos join ZeClinics!

They join ZeClinics as trainees, Mireia from Universitat Autónoma de Barcelona (UAB) and Ricardo from Instituto Español de Comercio Exterior (ICEX).

Read More
February 2018
12

CRISPR method efficiently corrects DMD defect in heart tissue

Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of mutations that cause DMD.

Read More